← Open Payments lookup

EMAN SHARAWY: Open Payments

NPI 1902998032 · GREENWOOD, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,882 in 106 payments from 14 companies in 2025. Trend: 2023 $1,589 · 2024 $1,965 · 2025 $1,882

Food & beverage: $1,882
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.14$320
Neurocrine BioSciences, Inc.14$252
E.R. Squibb & Sons, L.L.C.8$237
ABBVIE INC.20$205
Janssen Pharmaceuticals, Inc11$184
Teva Pharmaceuticals USA, Inc.12$139
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)5$120
Alkermes, Inc.6$111
Supernus Pharmaceuticals, Inc.5$91
Collegium Pharmaceutical, Inc.3$56

Products named: COBENFY, INGREZZA, VRAYLAR, ABILIFY ASIMTUFII, INVEGA SUSTENNA, CAPLYTA, REXULTI, Qelbree.

Industry payments across SC — which companies pay providers there.